 | Up a level |
Number of items: 1.
Elsby, Robert, Coghlan, Hannah, Edgerton, Jacob, Hodgson, David, Outteridge, Samuel and Atkinson, Hayley
(2023)
Mechanistic in vitro studies indicate that the clinical drug-drug interactions between protease inhibitors and rosuvastatin are driven by inhibition of intestinal BCRP and hepatic OATP1B1 with minimal contribution from OATP1B3, NTCP and OAT3.
PHARMACOLOGY RESEARCH & PERSPECTIVES, 11 (2).
e01060-.